Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
The American Journal of Managed Care
3h
Fexagratinib in MS Shows Promise for Human Use
Fexagratinib targets FGF, CSF, and VEGF pathways, showing potential in MS treatment by reducing inflammation and promoting ...
The American Journal of Managed Care
8h
Fixed-Duration 1L CLL Treatment Reduces Long-Term Costs in the Real World
The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...
The American Journal of Managed Care
22h
FDA Approves Obe-Cel for R/R B-Cell Acute Lymphoblastic Leukemia
Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
FBI thwarts Iranian plot
Resigns after election losses
Motion to vacate granted
Wins Nevada Senate race
To end debit card program
Medical worker gets 2 years
Asked to be US trade chief
Launches bid to chair NRSC
‘Candyman' star dies
Leads Grammy nominations
Philippines new maritime laws
IL weapons ban blocked
Hamas expulsion threatened
Global food prices rise
Notre Dame bells ring again
Consumer sentiment rises
S&P 500 breaks 6,000 level
Gaza crossing to reopen?
2025 Grammy nominations
Seattle stabbing spree ends
Wildfires erupt in NJ
Philly transit strike delayed
Rockefeller tree arrives
LA blaze under control
Hits $1 trillion market cap
Suit over Philly ballots
US energy revenue 2024
NC highway shootings arrest
Hurricane Rafael tracker
Canada shuts down offices
Salisbury hate crime charges
Assigned to G-League
Feedback